Faster waning of the rubella-specific immune response in young pregnant women immunized with MMR at 15 months.

作者: Wan‐Ju Kung , Ching‐Tang Shih , Yung‐Luen Shih , Ling‐Yao Liu , Chiou‐Huey Wang

DOI: 10.1111/AJI.13294

关键词:

摘要: PROBLEM Vaccination is the best protection against rubella and congenital infection. Although a high rate of immunization coverage achieved in Taiwan, it unknown if vaccine-induced immunity persists from age vaccination to childbearing age. METHODS OF STUDY A total 5,988 prenatal IgG test results young pregnant women aged 19-23 years old six hospitals during January 2001 December 2008 2013 2017 were analyzed. We compared seropositivity rates titers these who vaccinated with MMR vaccine four different cohorts. RESULTS The overall was 87.4% (95% CI: 86.6%-88.3%), mean level 39 IU/mL among 19-23 years. Women elementary cohort had highest positivity 90.8% 89.6%-91.9%), levels gradually decrease 84.6% 82.4%-86.7%) 15-month plus cohort. average only 25 IU/mL for cohorts immunized at younger exhibited significantly lower chances being seropositive relative older after adjusting other factors (all P < .01). CONCLUSION low 19-23 years, especially As wanes over time, third dose may be protective strategy conceive later life.

参考文章(33)
P Tookey, Rubella in England, Scotland and Wales. Eurosurveillance. ,vol. 9, pp. 21- 22 ,(2004) , 10.2807/ESM.09.04.00464-EN
Inna G. Ovsyannikova, Hannah M. Salk, Beth R. Larrabee, V. Shane Pankratz, Gregory A. Poland, Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children Immunogenetics. ,vol. 67, pp. 547- 561 ,(2015) , 10.1007/S00251-015-0864-Z
Michael E. Pichichero, Challenges in vaccination of neonates, infants and young children Vaccine. ,vol. 32, pp. 3886- 3894 ,(2014) , 10.1016/J.VACCINE.2014.05.008
Alba Vilajeliu, Alberto L. García-Basteiro, Salomé Valencia, Saul Barreales, Laura Oliveras, Valentín Calvente, Anna Goncé, José M. Bayas, Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain. Vaccine. ,vol. 33, pp. 1767- 1772 ,(2015) , 10.1016/J.VACCINE.2015.02.043
Ning Song, Zhanhai Gao, James G. Wood, Linda Hueston, Gwendolyn L. Gilbert, C. Raina MacIntyre, Helen E. Quinn, Robert Menzies, Peter McIntyre, Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination. Vaccine. ,vol. 30, pp. 4073- 4078 ,(2012) , 10.1016/J.VACCINE.2012.04.025
Inna G. Ovsyannikova, V. Shane Pankratz, Beth R. Larrabee, Robert M. Jacobson, Gregory A. Poland, HLA genotypes and rubella vaccine immune response: additional evidence. Vaccine. ,vol. 32, pp. 4206- 4213 ,(2014) , 10.1016/J.VACCINE.2014.04.091
Corinne Vandermeulen, Roelants Mathieu, Leroux-Roels Geert, Van Damme Pierre, Hoppenbrouwers Karel, Long-term persistence of antibodies after one or two doses of MMR-vaccine Vaccine. ,vol. 25, pp. 6672- 6676 ,(2007) , 10.1016/J.VACCINE.2007.07.008
Gaby Smits, Liesbeth Mollema, Susan Hahné, Hester de Melker, Irina Tcherniaeva, Fiona van der Klis, Guy Berbers, Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage Vaccine. ,vol. 32, pp. 1890- 1895 ,(2014) , 10.1016/J.VACCINE.2014.01.066
D.J. Nokes, R.M. Anderson, Measles, mumps, and rubella vaccine: what coverage to block transmission? The Lancet. ,vol. 332, pp. 1374- 1374 ,(1988) , 10.1016/S0140-6736(88)90920-8